Azurity Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
8 Cabot Rd Ste 2000, Woburn, Massachuset...Phone Number
(800) 461-7449Website
www.azurity.comRevenue
$270.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
8
1
2
2
2
1
About Azurity Pharmaceuticals
Azurity Pharmaceuticals is a privately held biopharmaceutical company focused on developing and delivering innovative, high-quality medicines for underserved patients. With a diverse portfolio across multiple therapeutic areas and dosage forms, the company leverages advanced commercial strategies, data, and digital tools to enhance reach and engagement, aiming to improve patient outcomes and address unmet medical needs globally.Explore more
Azurity Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Azurity Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Azurity Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Azurity Pharmaceuticals has new funding data
Check out if Azurity Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Azurity Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Azurity Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Azurity Pharmaceuticals
Website visits: Recent activity has been detected on your website
Click to see if Azurity Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Azurity Pharmaceuticals recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Azurity Pharmaceuticals
Compare insights from companies similar to Azurity Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Azurity Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Azurity Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Azurity Pharmaceuticals.
Azurity Pharmaceuticals Tech Stack
A closer look at the technologies used by Azurity Pharmaceuticals
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Azurity Pharmaceuticals News & Media
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
PETACH TIKVA, Israel, July 21, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins, today announced that it has entered into an exclusive commercial partnership agreement (the “Agreement”) with Azurity Pharmaceuticals (“Azurity”), a privately held specialty pharmaceutical company, for the commercialization of D-PLEX100 in the United States and Canada forMatinas BioPharma to merge into GH Power clean energy firm | MTNB Stock News
Planned deal would give GH Power a NYSE listing and Matinas holders about 9% of the new company, while Azurity pays $4M plus up to $17.5M for MAT2203.Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals
Will create publicly traded advanced clean energy company focused on modular carbon-free energy, green hydrogen, critical materials and industrial decarbonizationAzurity Pharmaceuticals Announces FDA Approval of Aprepitant Injectable Emulsion, Expanding Access to Critical Supportive Oncology Care
Ready-to-use formulation to help treatment preparation without the use of polysorbate-80 Ready-to-use formulation to help treatment preparation without the use of polysorbate-80
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Azurity Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Azurity Pharmaceuticals is a privately held biopharmaceutical company focused on developing and delivering innovative, high-quality medicines for underserved patients. With a diverse portfolio across multiple therapeutic areas and dosage forms, the company leverages advanced commercial strategies, data, and digital tools to enhance reach and engage... Read More
